4.6 Article

Neuroprotective factors affect the progression of Alzheimer's disease

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Mild Cognitive Impairment: Diagnosis and Subtypes

Nicholas Bradfield

Summary: Mild cognitive impairment (MCI) is a clinical diagnosis based on subjective cognitive decline, objective cognitive impairment, and relative preservation of activities of daily living. Various consensus groups have proposed different criteria for MCI in different neurodegenerative disorders, highlighting the subtle but important differences in diagnostic criteria. Once diagnosed, MCI can be further classified into four subtypes based on the pattern of cognitive impairment. The main utilities of MCI as a nosology are to understand the natural history of neurodegenerative disorders, identify those at increased risk of developing dementia, and select individuals for potential treatments.

CLINICAL EEG AND NEUROSCIENCE (2023)

Article Biochemistry & Molecular Biology

TOMM40 Genetic Variants Cause Neuroinflammation in Alzheimer's Disease

Yi-Chun Chen et al.

Summary: This study identified six variants of the TOMM40 gene in Taiwanese AD patients using next-generation sequencing, and found that two variants (rs157581 and rs11556505) were associated with increased AD risk. Cell models experiments further showed that these variants caused mitochondrial dysfunction, microglial activation, and neuroinflammation. In addition, AD patients carrying these variants exhibited elevated levels of inflammatory cytokines in plasma.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Alzheimer's Disease: An Updated Overview of Its Genetics

Jesus Andrade-Guerrero et al.

Summary: Alzheimer's disease (AD) is a common neurodegenerative disease that can be familial or sporadic. Genetic mutations in PSEN1, PSEN2, or APP are associated with familial early-onset AD, while sporadic late-onset AD is mainly linked to aging. Many polymorphisms associated with AD have been identified through GWAS. This review aims to analyze the new genetic findings related to AD pathophysiology and the mutations associated with high or low risk of developing this neurodegenerative disease identified by GWAS. Understanding genetic variability can help in early biomarker identification and the development of therapeutic targets for AD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Clinical Neurology

Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease

Linda Soderberg et al.

Summary: Immunotherapy targeting amyloid-beta (A ss) shows promise in treating Alzheimer's disease (AD). This study characterized the binding properties of three antibodies (lecanemab, aducanumab, and gantenerumab) to various A ss species and found different binding preferences, which may explain the variability in clinical efficacy and side effects observed for these antibodies.

NEUROTHERAPEUTICS (2023)

Article Biochemistry & Molecular Biology

The Effects of PP2A Disruption on ER-Mitochondria Contact and Mitochondrial Functions in Neuronal-like Cells

Phaewa Chaiwijit et al.

Summary: Mitochondria-associated membranes (MAMs) play a critical role in regulating cellular processes such as calcium homeostasis and mitochondrial function and dynamics. In Alzheimer's disease (AD), MAMs are upregulated, but the mechanisms behind this increase are still unclear. This study explores the correlation between protein phosphatase 2A (PP2A) and MAMs in neuronal-like cells. The inhibition of PP2A activity leads to increased MAM formation, disrupted mitochondrial function, and dynamics.

BIOMEDICINES (2023)

Article Multidisciplinary Sciences

An Alzheimer's disease category progression sub-grouping analysis using manifold learning on ADNI

Dustin van der Haar et al.

Summary: In this study, various statistical and machine learning methods were used to analyze health record data related to Alzheimer's disease (AD) and explore its patterns for further categorization. Different manifolds were applied and the clustering potential of the learned embeddings was determined. The results reveal sub-groupings within the existing AD categories, particularly in the transition of mild cognitive impairment, suggesting a need for additional sub-categories to describe AD progression.

SCIENTIFIC REPORTS (2023)

Review Biochemistry & Molecular Biology

Ribosome biogenesis in disease: new players and therapeutic targets

Lijuan Jiao et al.

Summary: The ribosome is responsible for translating mRNA into protein and ribosome biogenesis plays a crucial role in various cellular processes. mTORC1, Myc, and noncoding RNA signaling pathways, along with RNA polymerases and ribosome proteins, regulate ribosome biogenesis and protein synthesis. Dysregulation of these pathways is implicated in various diseases including cancer, neurodegenerative diseases, and atherosclerosis.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Article Clinical Neurology

Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease

Linda Soderberg et al.

Summary: The study revealed different binding profiles of lecanemab, aducanumab, and gantenerumab to various species of Aβ, which may explain the varying clinical outcomes and side effects observed for these antibodies.

NEUROTHERAPEUTICS (2023)

Article Clinical Neurology

Brain 18F-Florbetapir PET/CT Findings in an Early-onset Alzheimer Disease Patient Carrying Presenilin-1 G378E Mutation

Angelina Cistaro et al.

Summary: Positron emission tomography (PET) with F-18-Fluorodeoxyglucose (F-18-FDG) is essential for diagnosing dementia, and amyloid PET imaging is helpful for early detection of Alzheimer disease (AD). This study presents the first report of F-18-Florbetapir amyloid imaging in a 35-year-old male patient with early-onset Alzheimer disease (EOAD). The findings support the usefulness of amyloid PET imaging in diagnosing EOAD.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2022)

Article Engineering, Biomedical

Three-dimensional-engineered bioprinted in vitro human neural stem cell self-assembling culture model constructs of Alzheimer's disease

Yi Zhang et al.

Summary: This study presents a 3D core-shell Alzheimer's disease (AD) model construct, generated using bioprinting technology, to mimic the neural tissue microenvironment. The construct exhibits cell self-clustering and -assembling properties, and shows different effects on the growth and gene expression of neural progenitor cells compared to 2D and 3D MIX models.

BIOACTIVE MATERIALS (2022)

Article Neurosciences

Methylation differences in Alzheimer's disease neuropathologic change in the aged human brain

Anna-Lena Lang et al.

Summary: This study focuses on the epigenetic study of ADNC in individuals over 90 years old and finds that the dentate gyrus region has the highest DNA methylation differences, which are significantly associated with increased burden of amyloid beta plaques. Additionally, the study provides the most detailed array-based methylation survey of the old aged human brain to date and presents an open-sourced dataset.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Review Biochemistry & Molecular Biology

Disclosure of Genetic Risk Factors for Alzheimer's Disease to Cognitively Healthy Individuals-From Current Practice towards a Personalised Medicine Scenario

Samantha Galluzzi et al.

Summary: Alzheimer's disease is a genetically complex disorder with multiple risk loci, including the Apolipoprotein E gene. While genetic testing for AD susceptibility is not recommended for cognitively healthy adults, clinical trials and direct-to-consumer testing provide opportunities for individuals to learn about their genetic risk profile for AD.

BIOMEDICINES (2022)

Article Neurosciences

Scavenging Reactive Oxygen Species Decreases Amyloid-β Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells

Yan Peng et al.

Summary: This study reveals that impaired glucose uptake in Alzheimer's disease is caused by the decreased expression of GLUT1. Scavenging ROS with NAC and activating Akt with SC79 can restore glucose uptake.

JOURNAL OF ALZHEIMERS DISEASE (2022)

Review Biochemistry & Molecular Biology

Therapeutic approaches of nutraceuticals in the prevention of Alzheimer's disease

Surya Nath Pandey et al.

Summary: Alzheimer's disease is a neurological illness that causes memory loss. Nutraceuticals have shown significant effects in treating the disease, with fewer side effects and easy availability. Further research and clinical trials are needed to confirm their impact.

JOURNAL OF FOOD BIOCHEMISTRY (2022)

Article Cell Biology

Willin/FRMD6 Mediates Mitochondrial Dysfunction Relevant to Neuronal Aβ Toxicity

Doris Chen et al.

Summary: This study identifies Willin/FRMD6 as a potential risk gene for Alzheimer's disease (AD), and demonstrates the direct effects of A beta on its expression. The study also reveals mitochondrial oxidative stress as a novel mechanism underlying the role of Willin/FRMD6 in AD pathogenesis. Additionally, the study shows that knockdown of Willin/FRMD6 leads to mitochondrial dysfunction and upregulation of ERK1/2 signaling, which are key early features of AD. Increasing Willin/FRMD6 expression may serve as a therapeutic strategy for protecting against A beta-induced mitochondrial and neuronal dysfunction.

CELLS (2022)

Review Neurosciences

Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer's and Parkinson's Diseases

Sonia Mayo et al.

Summary: Research has shown that microRNAs and DNA methylation may serve as potential diagnostic biomarkers in Alzheimer's disease and Parkinson's disease patients. Meanwhile, certain proteins show differential expression levels in the plasma of disease patients and healthy individuals. Despite the identification of specific biomarkers, clinical validation remains a common issue.

CURRENT NEUROPHARMACOLOGY (2021)

Article Genetics & Heredity

PLD3 is a neuronal lysosomal phospholipase D associated with β-amyloid plaques and cognitive function in Alzheimer's disease

Alex G. Nackenoff et al.

Summary: PLD3 is a lysosomal phospholipase D that plays a role in AD and cognition. PLD3 expression levels are associated with beta-amyloid plaque density and cognitive decline.

PLOS GENETICS (2021)

Article Cell Biology

Neuronal Dynamics and miRNA Signaling Differ between SH-SY5Y APPSwe and PSEN1 Mutant iPSC-Derived AD Models upon Modulation with miR-124 Mimic and Inhibitor

Goncalo Garcia et al.

Summary: Neuronal miRNA dysregulation may play a role in Alzheimer's disease pathophysiology, with miR-124 being a critical player in neuronal function. The role of miR-124 may vary depending on the neuronal AD model, but strict control of miR-124 levels is crucial for proper neuronal function. The iNEU-PSEN cellular model shows promise for AD mechanistic studies and personalized therapeutic strategies.

CELLS (2021)

Article Cell Biology

Dissociable effects of APOE ε4 and β-amyloid pathology on visual working memory

Kirsty Lu et al.

Summary: Research shows that APOE epsilon 4 carriers demonstrate superior performance in visual working memory, even in older age and in preclinical stages of Alzheimer's disease, suggesting the benefits of this genotype.

NATURE AGING (2021)

Article Clinical Neurology

Dysregulation of histone acetylation pathways in hippocampus and frontal cortex of Alzheimer?s disease patients

Estelle Schueller et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

Innovative IgG Biomarkers Based on Phage Display Microbial Amyloid Mimotope for State and Stage Diagnosis in Alzheimer's Disease

Laura M. De Plano et al.

ACS CHEMICAL NEUROSCIENCE (2020)

Article Multidisciplinary Sciences

Regulation of lifespan by neural excitation and REST

Joseph M. Zullo et al.

NATURE (2019)

Review Cell Biology

Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease

Isaac G. Onyango

NEURAL REGENERATION RESEARCH (2018)

Article Biochemistry & Molecular Biology

A novel Alzheimer disease locus located near the gene encoding tau protein

G. Jun et al.

MOLECULAR PSYCHIATRY (2016)

Article Geriatrics & Gerontology

ABCA7 p.G215S as potential protective factor for Alzheimer's disease

Celeste Sassi et al.

NEUROBIOLOGY OF AGING (2016)

Article Biotechnology & Applied Microbiology

Genome-wide association data classification and SNPs selection using two-stage quality-based Random Forests

Thanh-Tung Nguyen et al.

BMC GENOMICS (2015)

Article Clinical Neurology

Clinical Relevance of Apolipoprotein E Genotyping Based on a Family History of Alzheimer's Disease

Hilmar K. Lueckhoff et al.

CURRENT ALZHEIMER RESEARCH (2015)

Article Multidisciplinary Sciences

Integrative analysis of 111 reference human epigenomes

Anshul Kundaje et al.

NATURE (2015)

Article Multidisciplinary Sciences

Common genetic variants influence human subcortical brain structures

Derrek P. Hibar et al.

NATURE (2015)

Article Multidisciplinary Sciences

Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease

Elizabeta Gjoneska et al.

NATURE (2015)

Article Geriatrics & Gerontology

Tau immunization: a cautionary tale?

Alexandra J. Mably et al.

NEUROBIOLOGY OF AGING (2015)

Article Geriatrics & Gerontology

The influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease

Eva Louwersheimer et al.

NEUROBIOLOGY OF AGING (2015)

Article Neurosciences

Increased acetyl and total histone levels in post-mortem Alzheimer's disease brain

Pritika J. Narayan et al.

NEUROBIOLOGY OF DISEASE (2015)

Article Neurosciences

Evaluation of Candidate Genes Related to Neuronal Apoptosis in Late-Onset Alzheimer's Disease

Sonia Moreno-Grau et al.

JOURNAL OF ALZHEIMERS DISEASE (2015)

Article Neurosciences

Genetic Variants of GSK3B are Associated with Biomarkers for Alzheimer's Disease and Cognitive Function

Petronella Kettunen et al.

JOURNAL OF ALZHEIMERS DISEASE (2015)

Article Neurosciences

Progranulin and Amyloid-beta Levels: Relationship to Neuropsychology in Frontotemporal and Alzheimer's Disease

Peter Koertvelyessy et al.

JOURNAL OF ALZHEIMERS DISEASE (2015)

Article Neurosciences

Distinct Expression of Long Non-Coding RNAs in an Alzheimer's Disease Model

Doo Young Lee et al.

JOURNAL OF ALZHEIMERS DISEASE (2015)

Article Neurosciences

Genetic Variation in Imprinted Genes is Associated with Risk of Late-Onset Alzheimer's Disease

Mamoonah Chaudhry et al.

JOURNAL OF ALZHEIMERS DISEASE (2015)

Article Geriatrics & Gerontology

Angiotensin Converting Enzyme Inhibitors and Alzheimer Disease in the Presence of the Apolipoprotein E4 Allele

Wendy Wei Qiao Qiu et al.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2014)

Article Biochemistry & Molecular Biology

Lessons from a Failed γ-Secretase Alzheimer Trial

Bart De Strooper

Article Behavioral Sciences

Feelings Without Memory in Alzheimer Disease

Edmarie Guzman-Velez et al.

COGNITIVE AND BEHAVIORAL NEUROLOGY (2014)

Review Clinical Neurology

Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies

John M. Ringman et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2014)

Article Biochemistry & Molecular Biology

MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease

Julia Banzhaf-Strathmann et al.

EMBO JOURNAL (2014)

Article Clinical Neurology

Mild Cognitive Impairment and Asymptomatic Alzheimer Disease Subjects: Equivalent β-Amyloid and Tau Loads With Divergent Cognitive Outcomes

Diego Iacono et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)

Article Neurosciences

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease

Christopher W. Medway et al.

MOLECULAR NEURODEGENERATION (2014)

Article Multidisciplinary Sciences

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

Carlos Cruchaga et al.

NATURE (2014)

Article Multidisciplinary Sciences

REST and stress resistance in ageing and Alzheimer's disease

Tao Lu et al.

NATURE (2014)

Article Geriatrics & Gerontology

Hippocampus-specific deficiency in RNA editing of GluA2 in Alzheimer's disease

Inna Gaisler-Salomon et al.

NEUROBIOLOGY OF AGING (2014)

Review Neurosciences

Protein phosphatase 2A dysfunction in Alzheimer's disease

Jean-Marie Sontag et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)

Review Neurosciences

Neuronal dark matter: the emerging role of microRNAs in neurodegeneration

Emily F. Goodall et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2013)

Article Biochemistry & Molecular Biology

Aging and epigenetics Longitudinal changes in gene-specific DNA methylation

Jaime Madrigano et al.

EPIGENETICS (2012)

Article Multidisciplinary Sciences

A mutation in APP protects against Alzheimer's disease and age-related cognitive decline

Thorlakur Jonsson et al.

NATURE (2012)

Article Multidisciplinary Sciences

An epigenetic blockade of cognitive functions in the neurodegenerating brain

Johannes Graeff et al.

NATURE (2012)

Article Biochemical Research Methods

Targeted proteomics for quantification of histone acetylation in Alzheimer's disease

Kangling Zhang et al.

PROTEOMICS (2012)

Article Biochemistry & Molecular Biology

Identification of Candidate IgG Biomarkers for Alzheimer's Disease via Combinatorial Library Screening

M. Muralidhar Reddy et al.

Article Biochemistry & Molecular Biology

In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs

Pascal Smith et al.

JOURNAL OF NEUROCHEMISTRY (2011)

Review Biotechnology & Applied Microbiology

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

Harald Hampel et al.

NATURE REVIEWS DRUG DISCOVERY (2010)

Editorial Material Biotechnology & Applied Microbiology

Evidence for natural antisense transcript-mediated inhibition of microRNA function

Mohammad Ali Faghihi et al.

GENOME BIOLOGY (2010)

Article Clinical Neurology

Voxel-based analysis of cerebral glucose metabolism in mono- and dizygotic twins discordant for Alzheimer disease

J. J. Virta et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)